Pfizer has created a cure for COVID-19: how it works and when it goes on sale

Pfizer is beginning a global Phase 2/3 study of EPIC-PEP of a new oral antiviral drug against COVID-19 for post-exposure prophylaxis in adults, the pharmaceutical company reported on the official website of the pharmaceutical company. EPIC-PEP (Evaluation of COVID-19 Protease Inhibition in Post-Exposure Prophylaxis) is the third study launched as part of this global...

0 - 1 of 1